AIDSVAX B/B Trial Statistics

AIDSVAX B/B Trial Statistics

• Volunteers completing three doses: 5,009
• Placebo recipients: 1,679
• AIDSVAX B/B recipients: 3,330
• White volunteers: 4,185
• Hispanic volunteers: 326
• Non-white volunteers: 498
• Black volunteers: 314
• Annual study infection rate: 2.7%

Approximate efficacy (after at least 3 primary doses):

— All volunteers: 3.8% (p-value = 0.76)

— Non-white volunteers: 67% (p-value < 0.01)

— Black volunteers: 78% (p-value < 0.02)